Literature DB >> 3008478

The effect of oestrogen and relaxin on uterine and cervical enzymes: collagenase, proteoglycanase and beta-glycuronidase.

C K Too, J K Kong, F C Greenwood, G D Bryant-Greenwood.   

Abstract

Relaxin (Rlx) classically causes uterine quiescence during pregnancy and cervical dilatation prior to parturition. Its actions involve major changes in the components of the extracellular matrix of these tissues. The activities of three enzymes, collagenase, proteoglycanase and beta-glucuronidase, major determinants of the integrity of the extracellular matrix have been measured in the rat uterus and cervix in different reproductive states. The results show that there are marked differences in the changes of these enzymes occurring in the uterus and cervix during the course of pregnancy and the puerperium. It was not possible to directly relate these changes to a single hormonal event over this period of major endocrine fluctuations. Two models have therefore been used in an attempt to delineate the effects of oestrogen and Rlx on the tissue enzyme levels or their secretion into culture medium. In the first model cyclic animals were treated with oestrogen alone or oestrogen followed by Rlx and tissue enzyme levels measured. The addition of Rlx treatment reversed an inhibiting effect of oestrogen alone on both uterine and cervical collagenase and proteoglycanase activities, at the same time as completely obliterating the stimulating effect of oestrogen on uterine and cervical beta-glucuronidase activity. A second model used in vivo oestrogen priming of cyclic rats followed by in vitro Rlx treatment and measurement of the enzymes secreted into the culture medium over 7 days. The results showed as in the first model that Rlx treatment could in particular overcome the inhibiting effect of oestrogen on uterine proteoglycanase secretion without affecting beta-glucuronidase levels. In contrast, the effect of Rlx on the cervix was to decrease collagenase and proteoglycanase secretion whilst not affecting the beta-glucuronidase levels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008478     DOI: 10.1530/acta.0.1110394

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

1.  Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo.

Authors:  E J Williams; R C Benyon; N Trim; R Hadwin; B H Grove; M J Arthur; E N Unemori; J P Iredale
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  Relationship of relaxin hormone and thumb carpometacarpal joint arthritis.

Authors:  Jennifer Moriatis Wolf; Danielle L Scher; Eric W Etchill; Frank Scott; Allison E Williams; Steven Delaronde; Karen B King
Journal:  Clin Orthop Relat Res       Date:  2014-04       Impact factor: 4.176

3.  Female hormone receptors are differentially expressed in mouse fibrocartilages.

Authors:  W Wang; T Hayami; S Kapila
Journal:  Osteoarthritis Cartilage       Date:  2008-10-17       Impact factor: 6.576

4.  Collagenase activity in the cervix of non-pregnant and pregnant women.

Authors:  R Osmers; W Rath; B C Adelmann-Grill; C Fittkow; M Severényi; W Kuhn
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

5.  Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss.

Authors:  Gihan Hashem; Qin Zhang; Takayuki Hayami; Jean Chen; Wei Wang; Sunil Kapila
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

6.  Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants.

Authors:  Tabassum Naqvi; Trang T Duong; Gihan Hashem; Momotoshi Shiga; Qin Zhang; Sunil Kapila
Journal:  Arthritis Res Ther       Date:  2004-10-29       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.